Bentham Science Logo

Track Your Manuscript:


Clinical Cancer Drugs

Volume 7, 2 Issues, 2020
ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Clinical Cancer Drugs, Volume 3 - Number 1



Prostate Cancer Molecular Background: The IGF-1Ec Story

, 3(1): 6 - 15

Armakolas Athanasios and Koutsilieris Michael


DOI: 10.2174/2212697X03666151203202720



Castration-resistant Prostate Cancer: The Targeting of Bone Microenvironment-related Survival Factors For Prostate Cancer Cells

, 3(1): 16 - 22

Dimitrios Karamanolakis, Athanasios Armakolas and Michael Koutsilieris


DOI: 10.2174/2212697X03666151203202934



Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

, 3(1): 23 - 35

Lavinia Casati, Fabio Celotti and Valeria Sibilia


DOI: 10.2174/2212697X03666151207185452



Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

, 3(1): 36 - 62

Festuccia Claudio


DOI: 10.2174/2212697X0301160328201324



Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies

, 3(1): 63 - 73

Jianquan Wu, Chengcheng Hong, Hongjie Pan, Qingzhu Yang, Yu Mei, Q. Ping Dou and Huanjie Yang


DOI: 10.2174/2212697X03666160112001739




Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
(USA)
Biography
View Full Editorial Board

Journal History

Clinical Cancer Drugs was introduced in 2014 with the assistance of Dr. Giulio Francia, who is the current Editor-in-Chief serving since 2014.

Advertisement

Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog